join retatrutide trial 💉 may be redefining obesity treatment. New data from TRIUMPH-1 showed: 🔥 ~28% average weight loss over 80 weeks 🔥 >30% weight loss in nearly half of participant #ObesityMedicine #Retatrutide #GLP1 #CardioMetabolic Experimental drug retatrutide cut weight

Adding a copper-containing peptide to this population without monitoring creates a compounding risk that is entirely avoidable with baseline labs

These routes bypass first-pass metabolism, offering more reliable delivery to target tissues, especially in neuroendocrine and immunomodulatory applications

This typically means switching to a stronger medication or making dietary or exercise changes, although these measures do not always resolve the plateau

According to the American Journal of Clinical Nutrition, patients using GLP-1 medications can lose up to 25% of their weight as lean muscle rather than fat when protein intake drops below optimal levels

Vijay S, Brassier A, Ghosh A, Fecarotta S, Abel F, Marulkar S, Jones SA